Drug Trial Radar · NCT07285070
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Mar 16, 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Novaliq GmbHIndustry
- Sponsor type
- Industry
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.
Conditions
- Non-infectious Anterior Uveitis
Interventions
Tacrolimus ophthalmic solutionDrug
high and low dose treatment will be compared over 6 weeks treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: 8 weeks
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Horizon Eye & Lasik Center
Phoenix, Arizona
Bascom Palmer Eye Institute
Miami, Florida
Massachusetts Eye Research and Surgery Institution
Waltham, Massachusetts
Metropolitan Eye Research and Surgery Institute
Palisades Park, New Jersey
Valley Retina Institute, P.A.
McAllen, Texas
Virginia Eye Consultants
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.